1. Home
  2. STOK vs ZKH Comparison

STOK vs ZKH Comparison

Compare STOK & ZKH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STOK
  • ZKH
  • Stock Information
  • Founded
  • STOK 2014
  • ZKH 1998
  • Country
  • STOK United States
  • ZKH China
  • Employees
  • STOK N/A
  • ZKH N/A
  • Industry
  • STOK Biotechnology: Pharmaceutical Preparations
  • ZKH
  • Sector
  • STOK Health Care
  • ZKH
  • Exchange
  • STOK Nasdaq
  • ZKH Nasdaq
  • Market Cap
  • STOK 721.4M
  • ZKH 616.9M
  • IPO Year
  • STOK 2019
  • ZKH 2023
  • Fundamental
  • Price
  • STOK $12.03
  • ZKH $3.83
  • Analyst Decision
  • STOK Strong Buy
  • ZKH Strong Buy
  • Analyst Count
  • STOK 7
  • ZKH 2
  • Target Price
  • STOK $21.40
  • ZKH $12.65
  • AVG Volume (30 Days)
  • STOK 405.8K
  • ZKH 67.7K
  • Earning Date
  • STOK 11-05-2024
  • ZKH 11-22-2024
  • Dividend Yield
  • STOK N/A
  • ZKH N/A
  • EPS Growth
  • STOK N/A
  • ZKH N/A
  • EPS
  • STOK N/A
  • ZKH N/A
  • Revenue
  • STOK $16,742,999.00
  • ZKH $1,213,635,386.00
  • Revenue This Year
  • STOK $91.67
  • ZKH $4.02
  • Revenue Next Year
  • STOK $5.45
  • ZKH $16.24
  • P/E Ratio
  • STOK N/A
  • ZKH N/A
  • Revenue Growth
  • STOK 81.08
  • ZKH 2.49
  • 52 Week Low
  • STOK $3.77
  • ZKH $2.62
  • 52 Week High
  • STOK $17.58
  • ZKH $21.91
  • Technical
  • Relative Strength Index (RSI)
  • STOK 39.51
  • ZKH 54.01
  • Support Level
  • STOK $13.39
  • ZKH $3.75
  • Resistance Level
  • STOK $14.72
  • ZKH $4.03
  • Average True Range (ATR)
  • STOK 0.68
  • ZKH 0.23
  • MACD
  • STOK 0.03
  • ZKH -0.01
  • Stochastic Oscillator
  • STOK 7.24
  • ZKH 50.51

About STOK Stoke Therapeutics Inc.

Stoke Therapeutics Inc is engaged in addressing the underlying causes of severe diseases by upregulating protein expression with RNA-based medicines. Using its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, it is developing antisense oligonucleotides (ASOs) to selectively restore protein levels. Its first compound, STK-001, is in clinical testing for the treatment of Dravet syndrome, a severe and progressive genetic epilepsy. The company primarily operates in the U.S.

About ZKH ZKH Group Limited each representing thirty-five (35)

ZKH Group Ltd engages in providing MRO procurement service platform in China. It provides one-stop MRO procurement and management services for its customers, and offers digital and fulfillment solutions for participants along the industry value chain. It offers a broad range of MRO product offerings covering all MRO product lines on its platform, including spare parts, chemicals, manufacturing parts, general consumables, and office supplies. All of the Group's revenues are derived from the PRC.

Share on Social Networks: